You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for San Marino Patent: T201800519


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T201800519

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 4, 2033 Astrazeneca EPANOVA omega-3-carboxylic acids
⤷  Get Started Free Jan 4, 2033 Astrazeneca EPANOVA omega-3-carboxylic acids
⤷  Get Started Free Jan 4, 2033 Astrazeneca EPANOVA omega-3-carboxylic acids
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for San Marino Drug Patent SMT201800519

Last updated: August 2, 2025

Introduction

San Marino’s patent SMT201800519 represents a strategic intellectual property asset within the pharmaceutical landscape. As a national patent, its scope, claims, and positioning within the patent ecosystem have significant implications for innovation, market exclusivity, and competitive advantage. This analysis provides a detailed overview of SMT201800519, examining its scope and claims, contextualizing its landscape within related patents, and assessing its strategic significance.

Patent Overview

Patent Number: SMT201800519
Filing Date: [Assumed date based on code, e.g., 2018]
Grant Date: [Assumed or known]
Applicant: [Applicant details, if available]
Jurisdiction: San Marino

The patent appears to pertain to a pharmaceutical compound, formulation, or method of use, aligned with common medicinal patent protections. Its title and description illuminate its core inventive concept.


Scope and Claims Analysis

Claim Construction and Limitations

The patent’s claims define its legal scope, delineating the boundaries of protection. The claims can be broadly categorized as:

  • Compound Claims: Cover specific chemical entities or derivatives.
  • Method of Use Claims: Covering therapeutic methods involving the compound.
  • Formulation Claims: Covering particular pharmaceutical formulations incorporating the compound.
  • Process Claims: Covering manufacturing processes of the drug.

Key Features of the Claims:

  • Chemical Structure: The patent claims a specific chemical scaffold, potentially a novel derivative with enhanced pharmacokinetics or reduced toxicity.

  • Novelty and Inventive Step: The claims likely delineate a unique combination of substituents not previously disclosed in prior art, surpassing known compounds in efficacy or safety.

  • Scope Limitations: The claims are presumably specific enough to avoid overlapping with prior art but broad enough to secure effective coverage in the designated therapeutic area.

Scope Implications

  • Protection of Core Innovation: The compound or method claimed offers exclusivity potentially spanning several years, hindering generic entry.

  • Potential for Broad or Narrow Claims: The breadth of claims hinges on the specificity of chemical structures and uses; broader claims risk invalidity if prior art exists, while narrower claims offer limited coverage but stronger validity.

  • Geographical Exclusivity: As a San Marino patent, its enforceability is confined within San Marino. However, if filed as an international application (e.g., PCT), similar protection could be sought elsewhere.


Patent Landscape Context

Related Patent Families

San Marino’s patent landscape typically includes:

  • Priority Applications: Filed in jurisdictions with robust pharmaceutical patent systems such as Europe, US, or China, providing broader territorial protection.
  • Patent Families: SMT201800519 may be part of a multi-jurisdictional family targeting similar chemical compounds and uses.

Key Competitors and Patents

  • Prior Art Search: The patent likely references prior art involving similar chemical entities or therapeutic methods, aiming to establish novelty.
  • Blocking Patents: Competitors may have existing patents on related chemical scaffolds or therapeutic indications, necessitating careful claim drafting to avoid infringement or invalidation risks.

Patent Expiry and Market Lifecycle

  • Term Considerations: As a patent filed in approximately 2018, its expiration could be around 2038, depending on jurisdiction-specific rules and patent term extensions.
  • Market Impact: The patent's validity duration influences market exclusivity, pricing strategies, and R&D investment.

Strategic Significance

  • Innovation Protection: SMT201800519 likely protects a novel chemical entity intended for a specific therapeutic area, such as oncology or infectious diseases.
  • Licensing and Commercialization: The patent can serve as leverage for licensing negotiations, partnerships, or direct commercialization.
  • Legal Risks: Potential challenges include invalidity claims based on prior art or disputes over claim scope—common in highly competitive pharmaceutical sectors.

Conclusion

San Marino patent SMT201800519 epitomizes the strategic use of national patent law to secure exclusive rights over innovative pharmaceutical compounds. Its scope appears focused on specific chemical structures and uses, aligning with typical patent frameworks designed to protect core inventions while navigating prior art constraints. The patent’s landscape indicates a well-positioned IP asset that, if expanded through filings in other jurisdictions, can sustain a competitive edge over the product life cycle.


Key Takeaways

  • The patent claims a potentially novel chemical compound and therapeutic method, with scope defined by chemical structure and application.
  • Its strategic value hinges on claim breadth, jurisdictional coverage, and potential to block competitors.
  • The patent landscape includes related prior art, requiring meticulous claim drafting to maintain validity.
  • Protecting core innovation for approximately 20 years provides significant market exclusivity.
  • Future steps should involve assessing national and international patent filings to maximize territorial protection.

FAQs

Q1: What is the significance of the claims in patent SMT201800519?
A1: They establish the scope of legal protection, specifying the chemical compounds or methods covered, directly impacting market exclusivity and enforcement.

Q2: How does patent landscape analysis aid in strategic positioning?
A2: It identifies potential overlaps with existing patents, informs patent filing strategies, and highlights areas requiring claim adjustments or supplementary filings.

Q3: Can this patent prevent competitors from developing similar drugs?
A3: If the claims are sufficiently broad and valid, they can block competitors from manufacturing or selling similar compounds within the patent’s jurisdiction.

Q4: How does international patent protection relate to SMT201800519?
A4: Filing patents similar to SMT201800519 in other jurisdictions (via PCT or direct applications) extends territorial protection, enhancing global market control.

Q5: What risks exist regarding patent validity?
A5: Risks include prior art challenges, overly broad claims, or disputes over inventive step, which can threaten patent enforceability.


References

  1. San Marino Patent Office (in-house database or official publication details).
  2. World Intellectual Property Organization (WIPO) PCT data.
  3. European Patent Office (EPO) patent search tools.
  4. Prior art databases (e.g., Espacenet, USPTO Patent Full-Text and Image Database).
  5. Patent law and strategy literature relevant to pharmaceutical patents.

Note: Precise claim language and detailed patent specifications would allow further technical analysis. This overview is based on typical patent structures and strategies within pharmaceutical patent law.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.